SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

Students in Bucknell's creative writing program practice craft and technique, develop their style, and examine diverse voices in contemporary literature.

The English Department offers concentrations and certificates in multiple kinds of writing, from creative writing to science writing, and from technical writing to journalism.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

GPT-5, OpenAI's latest release, will decide for you which model is best for certain tasks. Here's the difference between them.